Gigantism is diagnosed through a combination of blood tests, imaging, and sometimes genetic screening. The process typically starts when a child’s growth rate is unusually fast or their height far exceeds what’s expected for their age and family. Because gigantism is rare and caused by excess growth hormone (GH) before a child’s growth plates have closed, catching it early matters for treatment outcomes.
Why Growth Plates Matter for Diagnosis
The distinction between gigantism and its adult counterpart, acromegaly, comes down to timing. Gigantism begins before the growth plates at the ends of long bones have fused, which is why it causes dramatic increases in height. Once those plates close (typically in the mid-to-late teens), excess growth hormone can no longer make bones longer. Instead, it thickens them, particularly in the hands, feet, and face, which is the hallmark of acromegaly. Both conditions stem from the same underlying problem: a pituitary gland producing too much growth hormone, usually because of a noncancerous tumor. But the age at onset shapes the diagnosis and the physical presentation.
Initial Signs That Prompt Testing
Most cases come to medical attention because a child is growing significantly faster than their peers. Parents or pediatricians may notice that the child’s height consistently tracks well above the 99th percentile on growth charts, or that their growth velocity is accelerating rather than following a normal curve. Shoe and clothing sizes may change rapidly. In some cases, children also develop headaches, vision changes, or joint pain, all of which can point toward a pituitary tumor pressing on surrounding structures.
A doctor will typically review the child’s growth records, family height patterns, and physical features before ordering blood work. Tall stature alone doesn’t indicate gigantism. Many tall children simply have tall parents. The red flag is a growth pattern that doesn’t match the family or that accelerates unexpectedly.
Blood Tests: IGF-1 and Growth Hormone
The first lab test is usually a measurement of insulin-like growth factor 1 (IGF-1). This protein circulates in the blood and reflects how much growth hormone the body has been producing over time. Think of it as a running average rather than a snapshot. If IGF-1 levels are elevated for the child’s age and sex, the next step is a more specific test to confirm the diagnosis.
That confirmatory test is the growth hormone suppression test, sometimes called the oral glucose tolerance test. The child drinks a sugary solution, and blood samples are drawn over the next couple of hours. In a healthy person, the sugar load triggers the body to temporarily shut down growth hormone production, dropping GH levels below 1 ng/mL. If GH stays stubbornly high and doesn’t suppress below that threshold, it’s strong evidence that the pituitary gland is overproducing growth hormone on its own, outside normal regulation. This is the key test that separates gigantism from other causes of tall stature.
Checking Other Pituitary Hormones
The pituitary gland produces several hormones beyond growth hormone, and a tumor large enough to cause gigantism can disrupt the gland’s other functions. For this reason, doctors typically run a broader hormone panel as part of the workup. Prolactin is one of the most important to check, because many GH-producing pituitary tumors also release excess prolactin. Elevated prolactin in a child can cause its own set of problems, including delayed puberty.
If the tumor is large (classified as a macroadenoma, meaning over 1 centimeter), the evaluation expands further. A large tumor can compress healthy pituitary tissue and reduce the gland’s ability to produce other essential hormones, a condition called hypopituitarism. In boys and adolescent males, testosterone levels are checked to assess whether reproductive hormone pathways are intact. Thyroid function and cortisol production may also be evaluated, since deficiencies in either can cause serious health problems if left untreated.
MRI of the Pituitary Gland
Once blood tests confirm excessive growth hormone production, an MRI of the brain focused on the pituitary gland is the standard next step. The goal is to locate and measure the tumor. Most cases of gigantism are caused by a somatotropinoma, a type of pituitary adenoma that specifically produces growth hormone. MRI reveals the tumor’s size, shape, and whether it’s extending into nearby structures like the optic nerves (which can explain vision problems). Tumor size also influences treatment planning, since smaller tumors are generally easier to remove surgically than larger ones that have grown beyond the pituitary’s bony enclosure.
Genetic Testing
Gigantism diagnosed in a very young child, or cases where multiple family members have pituitary tumors, often warrant genetic testing. One of the most relevant genes is AIP. Mutations in this gene account for 15 to 25 percent of cases of familial isolated pituitary adenoma (FIPA), an inherited condition in which noncancerous pituitary tumors run in families. People with AIP mutations most commonly develop exactly the type of tumor that causes gigantism: a somatotropinoma. These tumors tend to appear at a relatively young age, usually before 30, and are often large at the time of diagnosis.
Even in children with no family history of pituitary problems, AIP mutations are found in a small percentage of cases involving large tumors. Identifying a genetic cause matters for two reasons. First, it can guide how aggressively the condition is monitored and treated. Second, it allows family members to be screened before they develop symptoms. Other genetic conditions linked to GH-producing tumors include McCune-Albright syndrome and Carney complex, each of which has additional features that help doctors recognize them during evaluation.
What the Diagnostic Timeline Looks Like
For most families, the diagnostic process unfolds over several weeks. The initial blood work (IGF-1) can come back within days. If results are abnormal, the GH suppression test is scheduled as a separate appointment, and results are usually available within a week. An MRI can often be performed shortly after, though scheduling varies. Genetic testing, when indicated, takes longer, sometimes several weeks to a couple of months for results to return from specialized labs.
Throughout this process, the child’s growth continues to be monitored. In some cases, bone age X-rays of the hand and wrist are taken to assess how mature the growth plates are. This helps doctors estimate how much more growing the child is likely to do and informs decisions about the urgency of treatment. A child whose growth plates are still wide open has more potential for continued excessive growth, making timely intervention more important.